HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

ATAC-seq of pancreatic cancer patient derived cell lines (PDCLs). The objective was to establish differences between PDCLs that are sensitive and resistant to GSK3B inhibitor treatment.

胰腺癌患者来源细胞系（PDCLs）的转座酶可及性染色质测序（ATAC-seq）数据集。本研究旨在明确对糖原合成激酶3β（GSK3B）抑制剂治疗敏感与耐药的PDCLs之间的差异。